Information Library
High-quality studies
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Early Phase Optimization Strategies
November 18, 2009
As payers balk at rising drug prices and patent expirations threaten the industry’s revenue streams, pharmaceutical companies worldwide are looking for ways to cut costs associated with drug development and, simultaneously, speed the process up. -
QUINTILES PARTNERS WITH FOUNDATION TRUST & UNIVERSITY TO IMPROVE PATIENT CARE AND DRIVE EFFICIENCY IN CLINICAL RESEARCH
October 26, 2009 - A significant step in driving innovation, improving patient care and increasing efficiency in early stage clinical research was taken today with the announcement that two of the UK’s leading institutions - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London - have signed a collaborative agreement with Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. -
QUINTILES CONSULTING EXPLORES IMPACT OF COMPARATIVE EFFECTIVENESS RESEARCH ON DRUG DEVELOPMENT
October 21, 2009 – In a new report released today, John Doyle, Vice President and Practice Leader for Quintiles Consulting, and an expert on pharmaceutical market access, explores the complex issue of comparative effectiveness research (CER) and its strategic importance in successful and efficient biopharmaceutical development. -
Emerging Markets
September 29, 2009
If you’re looking for new ways to bring development costs down, you may be considering the advantages of conducting clinical trials in emerging markets. -
Treatment Satisfaction Questionnaire
September 25, 2009
When evaluating the quality of programs, services, and products, patient satisfaction is a useful patient reported outcome. It serves four interrelated but distinct purposes, permitting: 1) evaluation of the acceptability of care or treatments from the patients’ perspective; 2) comparison of health-care programs or treatment options; 3) identification of service or treatment approaches that require change; 4) screening of patients who are likely to become nonadherent to care plans or medication regimens For these reasons, satisfaction measures are often used to plan health-care delivery systems and develop pharmaceutical products or medical devises. -
Patient Management
September 25, 2009
Knowing how patients are responding to your drug in everyday life can unlock your brand’s market potential. From outcomes to proof of efficacy, real-world patient data can help support market access, payer reimbursement and — most important — help prescribers improve patient treatment and adherence. Through an exclusive partnership with Apollo Medical Systems, Innovex UK has developed a patient management data service that reports the real impact of your brand in the context of total patient management, quickly and cost-effectively. -
Asthma controlled in Poland
September 23, 2009
This case study reviews a 2007 pilot program using nurse advisors to identify patients with uncontrolled asthma in Poland. -
Nasal Influenza Vaccine
September 22, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a nasal influenza vaccine study in Argentina, Brazil and South Africa. -
Maximizing Post-Marketing Research for Robust ROI
September 18, 2009
Quintiles leveraged its expertise and resources in a large-scale observational study to produce valuable post-marketing data for commercial success. -
Simplifying a Complex Study with Precision Planning
September 17, 2009
Quintiles leveraged its data management expertise and strategic planning to deliver high-quality data from a complex large-scale, multi-country study.